Virology & Mycology
Open Access
ISSN: 2161-0517
ISSN: 2161-0517
Katherine Smith M
Senior Scientist, Arbovax, Inc
University of Virginia, USA
bio:Dr. Katherine Smith is a cell and molecular biologist with an interest in virus-cell interactions. Her academic research encompassed cell, developmental, and microbiological fields and employed the use of recombinant DNA techniques, antibody production and use, DNA and RNA analysis and quantification, and animal husbandry. She successfully cloned two novel genes during the course of her graduate career and engineered numerous mutant DNA constructs. Dr. Smith received her bachelors’ degree in Biology with honors from the University of North Carolina at Chapel Hill and obtained her Ph.D. in Cell Biology at the University of Virginia. After a post-doctorate tenure at the University of Virginia, she worked as a research scientist in the International Technology Assessment division of Battelle Memorial Institute prior to joining Arbovax as a Senior Scientist. At Arbovax, Dr. Smith is working on the production and testing of a novel live-virus vaccine for Dengue fever and other insect-transmitted viruses.
bio:Dr. Katherine Smith is a cell and molecular biologist with an interest in virus-cell interactions. Her academic research encompassed cell, developmental, and microbiological fields and employed the use of recombinant DNA techniques, antibody production and use, DNA and RNA analysis and quantification, and animal husbandry. She successfully cloned two novel genes during the course of her graduate career and engineered numerous mutant DNA constructs. Dr. Smith received her bachelors’ degree in Biology with honors from the University of North Carolina at Chapel Hill and obtained her Ph.D. in Cell Biology at the University of Virginia. After a post-doctorate tenure at the University of Virginia, she worked as a research scientist in the International Technology Assessment division of Battelle Memorial Institute prior to joining Arbovax as a Senior Scientist. At Arbovax, Dr. Smith is working on the production and testing of a novel live-virus vaccine for Dengue fever and other insect-transmitted viruses.